Related Experiment Video
Updated: Aug 24, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Chronic Kidney Disease and Post-Percutaneous Coronary Intervention Mortality in Patients With Left Main and
Neil Yager1, Krishnakumar Hongalgi1, Mikhail Torosoff1
1Division of Cardiology and Nephrology, Albany Medical College, Albany, New York.
Insights
Patients with chronic kidney disease (CKD) face higher mortality after nonemergent percutaneous coronary intervention (PCI). Advanced CKD significantly predicts death following PCI for left main coronary artery disease.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Interventional Cardiology
Background:
- Chronic kidney disease (CKD) patients are underrepresented in coronary artery disease (CAD) research.
- Investigating CKD's impact on CAD management outcomes is crucial.
Purpose of the Study:
- To analyze the effect of CKD on outcomes of elective percutaneous coronary intervention (PCI) for left main or left main-equivalent coronary artery disease.
Main Methods:
- Analysis of 2,956 elective PCI cases from the New York State Percutaneous Coronary Intervention Registry in 2015.
- Inclusion criteria: stable left main or equivalent CAD, elective PCI.
- Exclusion criteria: acute coronary syndromes, shock, prior coronary artery bypass surgery.
Main Results:
- Stage 4 or 5 CKD was a significant predictor of post-PCI mortality.
- Congestive heart failure and left main disease also predicted mortality.
- Outcomes were compared across different degrees of CKD.
Conclusions:
- Advanced CKD is associated with significantly increased mortality after nonemergent PCI.
- Findings highlight the heightened risk for CKD patients undergoing PCI for complex CAD.
Background:
Patients with chronic kidney disease are underrepresented in registries and in randomized trials of coronary artery disease management. To investigate effects of chronic kidney disease on outcomes of nonemergent percutaneous coronary intervention in patients with left main or left main-equivalent coronary artery disease, we analyzed data from the New York State Percutaneous Coronary Intervention Registry during the calendar year 2015, involving 2,956 elective percutaneous coronary intervention cases. Outcomes of percutaneous coronary intervention in patients with various degrees of chronic kidney disease and stable left main or left main-equivalent coronary artery disease were compared.
Methods:
Only patients with left main or left main-equivalent coronary artery disease and elective percutaneous coronary intervention were included in the study cohort. Patients with acute coronary syndromes within 24 hours of the index percutaneous coronary intervention, patients reported to be in shock, and patients with prior coronary artery bypass surgery were excluded from the study cohort.
Results:
In this cohort, stage 4 or 5 chronic kidney disease, current congestive heart failure, and left main disease remained statistically significant predictors of post-percutaneous coronary intervention mortality.
Conclusion:
Our findings in this large, statewide cohort indicate that advanced kidney disease is associated with markedly increased post-nonemergent percutaneous coronary intervention mortality.
More Related Videos
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Coronary Artery Disease V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention

